Clinical trials
Terminated Observational Hypersensitivity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Precision Therapeutics | 2 |
| Adiga Life Sciences, Inc. | 1 |
| GlaxoSmithKline | 1 |
| King Chulalongkorn Memorial Hospital | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Nova Scotia Health Authority | 1 |
| Reyhan Kaygusuz | 1 |
| University of Calgary | 1 |
| University of Nebraska | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypersensitivity | 13 |
| Asthma | 4 |
| Fallopian Tube Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Recurrence | 2 |
| Rhinitis, Allergic | 2 |
| Anaphylaxis | 1 |
| Dermatitis, Atopic | 1 |
| Endometrial Neoplasms | 1 |
| Eosinophilic Esophagitis | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.